NCT00300807View on ClinicalTrials.gov

Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection

PHASE1UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

April 30, 2007

Conditions
Hepatitis C
Interventions
DRUG

XTL 6865

Trial Locations (5)

10029

Mt Sinai School of Medicine, New York

22031

Metropolitan Research, Fairfax

27599

University Of North Carolina at Chapel Hill, Chapel Hill

46202

Indiana University School of Medicine, Indianapolis

Unknown

Hadassah University Hospital, Jerusalem

Sponsors
All Listed Sponsors
lead

XTL Biopharmaceuticals

INDUSTRY